Reclusive trader scores 20 years of winning trades. Learn how.
He had 20 straight years of winning trades without a single losing year… He had 20 straight years of winning trades without a single losing year…

And now, he is coming forward to share a brand-new forecast.
Click here to watch the video now.
Kathryn E. Wengel net worth and biography

Kathryn Wengel Biography and Net Worth

Kathy Wengel is Executive Vice President & Chief Global Supply Chain Officer for Johnson & Johnson, and a member of the Company’s Executive Committee. She has significant healthcare, operations and global business expertise – with more than three decades of experience in leadership positions with Johnson & Johnson.

In her current role, Kathy is responsible for all aspects of the development and implementation of the global Supply Chain for Johnson & Johnson, as well as its Quality & Compliance, Procurement, Environmental Health & Safety, Sustainability and Engineering & Property Services functions. A strong developer of globally diverse teams, Kathy leads an organization across three business segments: Pharmaceuticals, Medical Devices and Consumer Health.

Under Kathy’s leadership, Johnson & Johnson has been recognized by world-leading groups. The Company has been named #3 in both 2020 and 2021 on the Supply Chain Top 25 list by Gartner, Inc., the world’s leading research and advisory company. It also has the leading number of Lighthouse designations for its use of innovative technologies at production sites and other facilities – a designation granted by the World Economic Forum (WEF). Kathy is also one of the pioneers of the WEF’s Advanced Manufacturing Platform.

Since joining Johnson & Johnson in 1988, Kathy’s responsibilities have grown through a variety of strategic leadership and executive positions across the enterprise in multiple countries and in various roles within operations, quality, engineering, new product development, IT and other business functions. Kathy also served as the first Chief Quality Officer for Johnson & Johnson. During this time, she also co-led the design of the Company’s enterprise Supply Chain and Quality operating model. The effort brought together more than 20 disparate groups, all using core standards and operating principles, while delivering substantial value for the Company over the past decade.

Externally from Johnson & Johnson, Kathy serves as a member of the Board of Directors at LabCorp, a leading global life sciences company dedicated to using science to improve health and improve lives. She also serves as Chair of the Board of GS1 Global, a nonprofit that develops and maintains global supply chain standards. She is the Vice Chair of the Board of Directors at the National Association of Manufacturers in the U.S., and a member of the Board of Directors for the Manufacturing Institute. Kathy serves in several advisory capacities, including as member of the Executive Advisory Board for the Gartner Supply Chain practice and member of the Board of Advisors at AWESOME, a nonprofit working on the advancement of women in senior supply chain roles. Within Johnson & Johnson, Kathy is executive sponsor for the Women’s Leadership & Inclusion (WLI) initiative and the Women in Science, Technology, Engineering, Math, Manufacturing and Design (WiSTEM2D) program.

In 2019, Kathy was recognized by the Council of Supply Management Professionals (CSCMP) with its lifetime Distinguished Service Award, and she was elected to the Supply Chain Hall of Fame, the industry’s top individual supply chain honor. In 2015, Kathy received the National Association of Female Executives’ (NAFE) Women of Excellence Award and AWESOME’s Legendary Leadership Award in 2014.

Kathy holds a BSE degree in civil engineering and operations research from Princeton University.

What is Kathryn E. Wengel's net worth?

The estimated net worth of Kathryn E. Wengel is at least $11.61 million as of June 10th, 2022. Ms. Wengel owns 71,311 shares of Johnson & Johnson stock worth more than $11,608,005 as of October 6th. This net worth estimate does not reflect any other assets that Ms. Wengel may own. Learn More about Kathryn E. Wengel's net worth.

How do I contact Kathryn E. Wengel?

The corporate mailing address for Ms. Wengel and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400. Learn More on Kathryn E. Wengel's contact information.

Has Kathryn E. Wengel been buying or selling shares of Johnson & Johnson?

Kathryn E. Wengel has not been actively trading shares of Johnson & Johnson over the course of the past ninety days. Most recently, Kathryn E. Wengel sold 40,000 shares of the business's stock in a transaction on Friday, June 10th. The shares were sold at an average price of $173.00, for a transaction totalling $6,920,000.00. Following the completion of the sale, the executive vice president now directly owns 71,311 shares of the company's stock, valued at $12,336,803. Learn More on Kathryn E. Wengel's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), Kathryn Wengel (EVP), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 5 times. They sold a total of 106,842 shares worth more than $18,885,128.67. The most recent insider tranaction occured on June, 10th when EVP Kathryn E Wengel sold 40,000 shares worth more than $6,920,000.00. Insiders at Johnson & Johnson own 0.4 % of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 6/10/2022.

Kathryn E. Wengel Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/10/2022Sell40,000$173.00$6,920,000.0071,311View SEC Filing Icon  
9/2/2020Sell16,115$153.52$2,473,974.8066,658View SEC Filing Icon  
12/12/2019Sell2,017$141.07$284,538.1951,736View SEC Filing Icon  
See Full Table

Kathryn E. Wengel Buying and Selling Activity at Johnson & Johnson

This chart shows Kathryn E Wengel's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Read More

Today's Range

Now: $161.91
Low: $161.69
High: $165.00

50 Day Range

MA: $166.62
Low: $161.33
High: $174.59

2 Week Range

Now: $161.91
Low: $155.72
High: $186.69


5,860,524 shs

Average Volume

7,506,750 shs

Market Capitalization

$425.69 billion

P/E Ratio


Dividend Yield